MedPath

A clinical trial for assessment of Dexmedetomidine as an adjuvant to ropivacaine in ultrasound-guided Erector spinae plane block in paediatric abdominal surgeries.

Phase 3
Not yet recruiting
Conditions
Diseases of the digestive system, (2) ICD-10 Condition: K928||Other specified diseases of the digestive system, (3) ICD-10 Condition: K929||Disease of digestive system, unspecified,
Registration Number
CTRI/2024/06/069257
Lead Sponsor
Department of Anaesthesiology and Critical Care Jawaharlal Nehru Medical College AMU Aligarh
Brief Summary

Adequate postoperative pain assessment in pediatric patients may significantly improve their comfort and quality of life. ESP block is an emergency regional anaesthetic technique with significant potential and clinical benefit. ESP block provides visceral as well as somatic analgesia, relieves acute as well as chronic pain and can be utilized for analgesia at cervical, thoracic and abdominal levels with minimal side effects. ESPB have opioid sparing effect in pediatric patients, even in major surgeries. Dexmedetomidine has been shown to increase the duration of postop analgesia when used as an adjuvant in various nerve blocks in pediatric patients. In addition, dexmedetomidine provides a stable hemodynamic parameters and reduces the incidence of emergence delirium in pediatric patients. Available literature highlights the utility of Dexmedetomidine in terms of better analgesia and hemodynamic parameters when used as an adjuvant with ESPB in adults. The present study is designed to evaluate the efficacy of Dexmedetomidine as an adjuvant to Ropivacaine in bilateral ESP block in pediatric abdominal surgeries.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Consent of patient(>9yrs,parents/guardian ASA grade 1& 2 Weight between 10 kg to 30 kg Patients undergoing elective abdominal surgery under general anaesthesia.

Exclusion Criteria

No consent Allergy history Skin infection Deranged blood clotting Congenital abnormalities Systemic diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to first rescue analgesic.24 hrs
Secondary Outcome Measures
NameTimeMethod
1.Intraoperative & postoperative opioid requirement2.Postoperative pain score using CHEOPS scale

Trial Locations

Locations (1)

Jawaharlal Nehru Medical College AMU Aligarh

🇮🇳

Aligarh, UTTAR PRADESH, India

Jawaharlal Nehru Medical College AMU Aligarh
🇮🇳Aligarh, UTTAR PRADESH, India
Pooja Kumari Singh
Principal investigator
8789311383
pooja.ngr25@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.